Autophagy is a conserved, self-digestion process that is activated in response to nutrient limitation but acting also as an alternative death mechanism under certain conditions. It is accompanied by the progressive formation of vesicle structures from autophagosomes to autophagolysosomes orchestrated by autophagy effectors (Atg proteins) and modulators (that is, mTOR-mammalian target of rapamycin as a negative regulator). Malignant gliomas are highly resistant to current therapies that induce apoptosis, thus induction of the alternative cell death is an attractive strategy. We demonstrate that cyclosporine A (CsA, an immunophilin/calcineurin inhibitor) induces cell death with some apoptotic features but also accompanied by the appearance of numerous cytoplasmic vacuoles, immunostained for endoplasmic reticulum (ER) and autophagy markers. The induction of ER stress in glioma cells by CsA was evidenced by detection of unfolded protein response activation (phosphorylation of PERK, accumulation of IRE1a) and accumulation of ER stress-associated proteins (BIP and CHOP). Formation of the acidic vesicular organelles, increase of autophagic vacuoles, GFP-LC3 punctation (microtubule-associated protein light chain 3) and LC3-II accumulation upon CsA treatment confirmed activation of autophagy. Decrease of phosphorylation of 4E-BP1, p70S6K1 and its downstream target S6 ribosomal protein demonstrate inhibition of mTOR signaling by CsA. Salubrinal and silencing of PERK and IRE1a partially blocked CsA-induced accumulation of LC3-II. It suggests that ER stress precedes CsA-induced autophagy. Surprisingly, silencing of autophagy effectors ULK1, Atg5 or Atg7 increased the level of active caspases 3, 7 and PARP degradation in CsA-treated cells. Our results demonstrate that CsA induces both apoptosis and autophagy in malignant glioma cells via induction of ER stress and inhibition of mTOR/p70S6K1 pathway, however autophagy is cytoprotective in this context.
INTRODUCTION
Autophagy is a process for degrading proteins, organelles and recycling materials in response to cellular stress, accompanied by progressive development of vesicle structures from autophagosomes to autolysosomes. 1, 2 This evolutionary conserved process is controlled by more than 30 autophagy-related (Atg) proteins. 3, 4 The mammalian ortholog of yeast Atg1/unc-51-like kinase (ULK) complex, contributes to induction of autophagy and integrates signaling from mTOR kinase (mammalian target of rapamycin). 5, 6 The formation of the autophagosomes is mediated by two ubiquitin-like (Atg12 and Atg8/LC3) conjugation systems, which act sequentially. During the initiation step, Atg12 conjugates Atg5 and promotes the conjugation of microtubule-associated protein light chain 3 (LC3-I) to phosphatidylethanolamine that is required during the elongation step. Lipid conjugation leads to the conversion of the soluble form of LC3 (LC3-I) to the autophagicvesicle-associated form (LC3-II).
Some of core autophagy pathway components are directly controlled by cellular stress sensors, the best characterized being mTOR. 1, 7 mTOR Complex 1 (mTORC1) suppresses the initiation of autophagy, presumably through phosphorylation of the Ulk1-mAtg13-FIP200 complex. 5, 6 Upon activation, mTORC1 positively stimulates mRNA translation via 70 kDa ribosomal S6 kinase (p70S6K) and 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1). The suppression of mTOR inhibits cell growth and initiates the autophagic pathway. 8 Rapamycin is the mTORC1 inhibitor and induces autophagy in different tumor cells including glioma cells. 9 An increasing number of studies indicate that autophagy could be induced by unfolded protein response (UPR), the major endoplasmic reticulum (ER) stress pathway. 10 In mammalian cells, PERK (protein kinase-like endoplasmic reticulum kinase), IRE1 (inositol-requiring enzyme 1) and ATF6 (activating transcription factor 6) sense accumulation of unfolded proteins in the ER lumen and activate specific cellular response. 11 PERK phosphorylates the a subunit of the translation initiation factor, eIF2a, which attenuates general protein synthesis and initiates the selective translation of some stressresponsive transcripts. IRE1 is a serine/threonine kinase and also an endoribonuclease, which catalyzes the splicing of the mRNA encoding the transcription factor XBP-1 (X-box binding protein 1). PERK mediates transcriptional activation of LC3 and Atg5 proteins under hypoxic conditions via the transcription factors ATF4 (activating transcription factor 4) and CHOP (C/EBP homologous protein), respectively. 12 Signaling mechanisms linking ER stress to autophagy vary depending on specific stress conditions and organisms. 13, 14 Most chemotherapeutics induce cellular damage that triggers autophagy, but the impact of autophagy on tumor cell death or survival is unclear. Inhibition of autophagy promotes cell death 15, 16 and potentiates various anticancer therapies 17, 18 implicating autophagy as a cytoprotective mechanism. Inhibition 1 of autophagy at a late stage enhanced imatinib-induced cytotoxicity in human malignant glioma cells. 19 Blockade of lysosome acidification and degradation of autophagosomes by chloroquine and hydroxychloroquine together with conventional therapy for glioblastoma multiforme improves treatment outcomes 20 (http://clinicaltrials.gov/ct2/show/NCT00486603). Malignant gliomas are resistant to current therapeutic approaches, including neurosurgical resection, radiation and chemotherapy, partly due to frequent genomic alterations and activation of signaling cascades that prevents apoptosis. 21, 22 Recently autophagy emerged as a promising therapeutic concept, 23 as autophagy rather than apoptosis accompanies temozolomide, arsenic trioxide, C 2 -ceramide, cannabinoids and curcumin-induced cytotoxicity in glioma cells. [24] [25] [26] [27] [28] Thus, autophagy appears to be a double-edge sword that could be either protective or detrimental depending on stimuli and extent of autophagy induced. 29 Cyclosporine A (CsA), an immunophilin/calcineurin inhibitor, is an immunosuppressive agent that acts by binding and inhibiting cyclophilins and calcium-regulated phosphatase-calcineurin. Cyclophilin A, a primary target of CsA, is a peptidyl-prolyl isomerase implicated in the maturation and folding of native proteins. 30 We previously demonstrated that CsA induces cell death of rat C6 glioma cells with several apoptotic features, and either growth arrest or non-apoptotic programmed cell death in human malignant glioma cells. [31] [32] [33] CsA-induced death was accompanied by formation of numerous cytoplasmic vacuoles. In the present study, using a panel of malignant glioma cell lines, we sought to determine whether ER stress and autophagy contribute to CsA-induced glioma cell death. We demonstrate appearance of several autophagy features after CsA treatment, inhibition of mTOR signaling and induction of ER stress in glioma cells. Using pharmacological or genetic blockers of ER stress (salubrinal and PERK or IRE1 siRNA), we show that ER stress precedes CsA-induced autophagy. Suppression of autophagy by silencing of essential autophagy genes augmented apoptotic effects of CsA. In summary, we show involvement of ER stress/ autophagy pathways into CsA-induced programmed cell death of malignant glioma cells and present evidence that autophagy has cytoprotective rather than cytotoxic role in that process.
RESULTS

CsA triggers programmed cell death associated with vacuolation in glioma cells
We compared efficacy of CsA-induced cell death with common apoptosis inducers: UVC and adriamycin (Adr, doxorubicin). The IC50 for UVC, Adr and CsA on rat C6 glioma cells were 100 J/m 2 , 0.5 mg/ml and 60 mM, respectively. Three stimuli reduced cell viability to a similar degree ( Figure 1a ). All insults result in gradual appearance of biochemical hallmarks of apoptosis: cleaved fragments of caspase 7, caspase 3 and PARP (poly (ADP-ribose) polymerase-1), although they were not as prominent after CsA as after UVC or Adr treatments (Figure 1b ). UVC and Adr induced a 'ladder-like' oligonucleosomal DNA fragmentation in glioma cells similarly to irradiated Jurkat cells (Figure 1c) . Quantification of subdiploid cell population by flow cytometry confirmed an increase in DNA fragmentation after tested stimuli. However, the percentages of cells with fragmented DNA were lower after CsA exposure, when compared with UVC and Adr-treated cultures (10% versus 17% and 40%, respectively, Figure 1d ).
We observed formation of large vacuoles in rat and human glioma cells treated with CsA (Figure 1e ), which did not appear in cells treated with Adr or irradiated with UVC (not shown). Vacuolization induced in human glioma LN18 and T98G cells by CsA was completely blocked by actinomycin D (ActD) and cycloheximide (CHX), the inhibitors of transcription and translation, respectively (Supplementary Figure 1a) . A pan-caspase inhibitor, zVAD-FMK and CHX inhibited activation of caspase cascade in CsA-exposed glioma cells, indicating caspase participation in the execution of cell death (Figure 1f, Supplementary  Figure 1b) . The effects of cycloheximide could be due to blockade of de novo protein synthesis, attenuation of CsA-induced protein aggregate accumulation or both. Evidently, UVC irradiation and adriamycin induce apoptosis more potently than CsA, which triggers programmed cell death associated with vacuolation in studied glioma cells.
CsA induces ER stress response and activates UPR in human glioma cells CsA-induced vacuoles were transparent and lacked visible cytoplasmic materials (Figure 1e, Supplementary Figure 1a , 4a and b) that suggests their origin from fused and swollen ER cisternae. To verify this thesis, cells were stained with two ERspecific markers: calreticulin (an ER membrane, calcium-binding protein) and KDEL (retention sequence-marking proteins localized in ER). In control cells, ER had a reticular pattern, whereas following treatment with CsA, antibodies to ER markers stained numerous cytoplasmic vacuoles in LN18 and T98G glioma cells (Figure 2b, Supplementary Figure 4b) .
Accumulation of unfolded proteins in the ER triggers an UPR, the major ER stress pathway. Unfolded proteins are tagged for degradation with ubiquitin. We found that the level of ubiquitinated proteins increased gradually in glioma cells after exposure to CsA (Figure 2a) . We analyzed the levels of ER stress and UPR markers, such as IRE1a, PERK, CHOP and BIP. We observed accumulation of IRE1a and a shift of the PERK band (indicating its phosphorylation) from 5 h of treatment with CsA in human glioma cells. Phosphorylation of PERK at Thr980 was detected in CsAtreated C6 glioma cells (Supplementary Figure 2a) . The level of phosphorylated eIF2a increased 5 h posttreatment, but the effect was transient. The activation of IRE1a was confirmed by the presence of XBP-1 mRNA splice variants upon CsA treatment (Figure 2d ). Accumulation of BIP and CHOP followed the activation of kinases (Figure 2c, left panel) . The presented evidence indicate that CsA induces ER stress in malignant glioma cells, characterized by accumulation of ubiquitinated proteins, induction of an UPR and dilatation of ER cisternae.
We observed similar changes in malignant human glioma cells treated with typical ER stress inducers, for example, thapsigargin (Tg) and tunicamycin (Tm). Increases of IRE1alevel, phosporylation of PERK and accumulation of BIP and CHOP were observed in treated cells. In line with published data, that ER stress can induce autophagy in glioma cells, 28, 34 we confirmed that Tg and Tm increased the amount of LC3-II (Supplementary Figure 2b) .
CsA induces autophagy in glioblastoma cells
To examine whether CsA induces autophagy in glioma cells, we evaluated formation of acidic vesicular organelles (AVOs), associated with autophagy. We found an increase of AVOs in all studied glioma cells treated with CsA or Rap and decreased by coincubation with autophagy inhibitors 3 MA (3-methyladenine) or bafilomycin A1 (BafA1) (Supplementary Figures 3a and b) . Electron microscopy analysis was performed to detect autophagic alterations and autophagic vacuoles were counted. The number of autophagic vacuoles containing cellular material increased by 2.4-fold in glioma cells exposed to CsA (Figures 3a and b and Supplementary Figures 4a and b) .
The GFP-tagged LC3 plasmid was used to detect autophagy in cultured cells. As shown in Figures 3c and d distribution of GFP-LC3 in transfected untreated cells was diffused, however the cells with GFP-LC3 dots were observed and the percentage of these cells were different in distinct glioma cells. Interestingly, intact T98G had the highest level of endogenous autophagy, that was confirmed by LC3 conversion assay and quantitative electron microscopy (Figures 3a-e) . The treatment with Rap or CsA for 24 h increased GFP-LC3 punctation and the percentage of cells showing GFP-LC3 dots was higher in cells exposed to CsA than to Rap. The increase of GFP-LC3 punctation upon CsA treatment was statistically significant. The changes induced by CsA in C6, LN18 and T98G glioma cells were partially blocked by 3-methyladenine (Figure 3d ). We found that GFP-LC3 dots or autophagosomes localize close to cytoplasmic vacuoles/swollen ER cisternae (Supplementary Figures 4a and b) .
Immunoblots demonstrate the accumulation of endogenous LC3-II in glioma cells treated with CsA (Figure 3e ). In addition, co-incubation with BafA1, which blocks lysosomal degradation of CsA-induced autophagy is associated with inhibition of mTOR pathway We examined the effect of typical autophagy inducers, that is, rapamycin and starvation, on p70S6 kinase and 4E-BP1 (the two direct downstream effectors of mTORC1) in glioma cells. As shown in the Figure 4a , treatment with 50 nM Rap for 24 h or nutrients withdrawal for 1.5 h (Earle's basal salt solution) significantly reduced the levels of phospho-p70S6 kinase (Thr 389) and phospho-S6 ribosomal protein (Ser 235/236). The decrease in the level of phosphorylated 4E-BP1 (Thr 37/48) occurred only after starvation as shown previously. 35 We found that the levels of phosphorylated p70S6 kinase, S6 ribosomal protein and 4E-BP1 decreased gradually in human glioma cells after exposure to CsA (Figure 4b) . The phosphorylation of mTORC1 substrates was not affected in CsA-treated rat C6 glioma cells. Thus, CsA-induced autophagy is associated with mTORC1 inhibition in human glioma cells.
ER stress response develop prior to autophagy We tested whether alleviating ER stress could protect glioma cells from CsA-induced autophagy and cell death. Salubrinal has been reported to inhibit eIF2a dephosphorylation and protects cells from ER stress. 36 As shown in the Figure 5a , salubrinal induced both eIF2a phosphorylation and CHOP expression in glioma cells. Furthermore, salubrinal strongly reduced caspase 3 and PARP cleavage in CsA-treated cultures (Figure 5a ). CsA-induced decline of phospho-p70S6 kinase and 4E-BP1 levels was alleviated by salubrinal, whereas accumulation of LC3-II isoform was partially prevented (Figure 5b ).
Because of controversy concerning salubrinal, as an inhibitor of ER stress-mediated apoptosis, the expression of PERK and IRE1 was silenced using specific siRNAs. We observed strong (70-80%) silencing of PERK and IRE1 expression at the mRNA and protein levels (Figure 5c ). In contrary to salubrinal, knockdown of PERK, IRE1 or both kinases simultaneously increased the level of cleaved caspase 7. Similarly to salubrinal-treatment, downregulation of ER stress sensors was not sufficient to decrease CsA-induced upregulation of CHOP level. The accumulation of LC3-II isoform was partially blocked after silencing of PERK and IRE1 in glioma cells. These results suggest that salubrinal, in contrast to PERK and IRE1 silencing, differently regulates cell death induced by CsA. However, similar effects of salubrinal and PERK or/and IRE knockdown were observed on CsA-induced autophagy. These results suggest that ER stress is triggered prior to CsA-induced autophagy.
Inhibition of autophagy augments CsA-induced apoptotic cell death Inhibition of different stages of autophagy may result in different outcomes in glioma cells.
19,26 Therefore, we silenced Atg1/ULK1, implicated in the initiation of autophagy, and Atg5 and Atg7, required for autophagosome formation. We observed effective (60-70%) silencing of ULK1, Atg5, Atg7 at the mRNA and protein levels (Figures 6a and b) . To test whether autophagy controls the extent of CsA-induced death, we performed clonogenic survival assay after knockdown of autophagy regulators followed by treatment with CsA. Inhibition of autophagy increased the efficacy of CsA in reduction of colony formation (Figure 6c ) that suggests a protective role of autophagy.
The autophagy-related increase of the lipidated LC3-II isoform induced by CsA was partially abrogated after knockdown of Atg genes. Interestingly, the strongest inhibitory effect was observed in Atg5 siRNA-transfected cells, where the accumulation of autophagic LC3-II isoform decreased by three-fold in cells exposed to CsA (from 8.1 to 2.4) (Figure 6d ). The treatment of LN18 cells with CsA-induced caspases 3, 7 and PARP processing, and enhanced caspase 3 activity (comparing with untreated cells) and downregulation of ULK1, Atg5 or Atg7 expression augmented all events (Figures 6d-f) . Quantification of cleaved caspases and PARP demonstrated that the apoptosis rate in CsA-treated, Atg5-depleted cells was about two-fold higher than in the control siRNA-tranfected cells (siControl). Similar, although weaker effects, were produced by silencing of the other Atg genes. As described above, we found that genetic inhibition of autophagy at different levels enhanced the CsA-induced cell death suggesting a protective role of autophagy. 
CsA induces autophagy in intracerebral gliomas
We used a murine intracranial glioma model to determine whether CsA promotes autophagy in vivo. Prior to CsA administration in vivo, the effects of CsA were tested on cultured mouse glioma EGFP-GL261 cells. CsA decreased cell viability with the IC50 value at 10 mM. Cleaved caspase 3 and PARP were detected in cells treated with X10 mM CsA starting 15 h after treatment (Figure 7a ). The accumulation of LC3-II isoform in time-and dose-dependent These results demonstrate that CsA induces autophagy and ER stress response in EGFP-GL261 glioma cells (Figures 7b and c) .
We studied autophagy markers in experimental gliomas 15 days after implantation of EGFP-GL261 cells in control or CsA-treated mice (10 mg/kg/ip, every 2 days). As shown in the Figure 7d , the staining for LC3 in control brains was weak, but it was enhanced in tumor-bearing brains of CsA-treated mice. The vast majority of LC3 was detected in the cytoplasm, however nuclear localization was also detected. It demonstrates that CsA might induce autophagy in gliomas in vivo.
DISCUSSION
CsA at higher doses is cytotoxic in many organs 37, 38 and exerts antitumor activity towards several types of tumor cells. 31, 33, 39 Mechanisms underlying CsA-induced cytotoxicity are not elucidated. The present study demonstrates activation of autophagy and ER stress responses in malignant glioma cells exposed to CsA. This is supported by the following evidence: (1) CsAactivated autophagosome formation, detected by an increase of AVOs, electron microscopy and LC3 dots formation; (2) LC3 was converted from LC3-I to LC3-II; (3) CsA-induced accumulation of ubiquitinated proteins, activation of PERK and IRE1a pathways and accumulation of BIP and CHOP. Involvement of ER stress in CsAinduced cell death was demonstrated in tubular kidney cells. 40, 41 Similarly to our findings, they reported an early increase of BIP/GRP78, CHOP and PDI mRNA and protein levels. Interestingly, ultrastructural analysis of the kidney cortex of CsA-treated rats showed dilatations of ER cisternaes. We found numerous cytoplasmic vacuoles, immunostained for ER markers in different malignant glioblastoma cells exposed to CsA. CHX and ActD that block new protein synthesis, prevented appearance of CsA-induced cytoplasmic vacuolation and cell death (Supplementary Figure 1) . ER stress is induced by accumulation of unfolded proteins inside the lumen of the ER. CsA binds and inhibits the activity of the cyclophilin A (CyPA), a peptidyl-prolyl isomerase implicated in the maturation and folding of native proteins. 30 CyPA silencing was associated with induction of an UPR characterized by an increase of BIP/GRP78, CHOP transcripts and BIP/GRP78 protein expression. Knockdown of CyPA decreased cell viability. 40 Those results together with reported herein suggest that CyPA inhibition may contribute to CsA-induced ER stress. Our observations of cytotoxic effects of a non-immunosuppressive analog of CsA retaining a full capacity to inhibit cyclophilins, support such notion.
CsA-induced cell death of glioma cells is associated with the induction and processing of the autophagy marker LC3 (Figure 3) . CsA-induced increase of the GFP-LC3 punctation was partially blocked by 3-methyladenine. We also observed formation of AVOs in treated glioma cells. CsA induces LC3-II accumulation and formation of autophagosomes, visualized by electron microscopy, in glioma cells (Figure 3 ) and in human renal tubular cells. 41 The increase of LC3 in kidneys 41 and in intracranial gliomas of CsAtreated animals ( Figure 7) demonstrates that autophagy also occurs in vivo. In both types of cells (glioma and tubular cells), autophagy was dependent on ER stress, because salubrinal and silencing of PERK and/or IRE1 inhibited LC3-II accumulation. Moreover, in contrary to knockdown of PERK and/or IRE1, salubrinal significantly reduced cytotoxicity induced by CsA in glioma cells ( Figure 5 ) and in tubular cells. 40 Furthermore, selective silencing of ULK1, Atg5 or Atg7 increased the level of active caspase 3, 7 and PARP degradation in CsA-treated glioblastoma cells. Inhibition of autophagy with beclin1 siRNA significantly increased tubular cell death after CsA treatment. 41 Different basal level of autophagy in glioma cell lines and different effects of inhibitors of autophagy on these cells likely stem from various genetic alterations (for example, mutation in tumor suppressors PTEN or/and p53). Nevertheless, all presented results show that CsA-induced autophagy is rather cytoprotective in different cell types.
CsA-induced autophagy in glioma cells was associated with inhibition of mTOR pathway, reduction of phosphorylation of 4E-BP1, p70S6 kinase 1 and downstream S6 ribosomal protein (Figure 4) . Complex mTORC1 is regulated by the pro-survival kinase Akt, inhibition of which leads to mTORC1 inactivation and autophagy. 42 We have previously demonstrated that CsA downregulates Akt signaling and facilitates the activation of Forkhead family member (FKHR/FoxO1) resulting in transcriptional activation of the target gene, FasL. 43 Several studies of protein degradation during muscle atrophy show that FoxO3 (FoxO family member) can induce the expression of multiple autophagy genes, 44 and then upregulate autophagy. FoxO1 regulates the expression of key autophagy genes in hepatocytes in insulindependent manner. 45 Because of many genetic alterations, malignant gliomas are resistant to radiation or/and chemotherapy. Autophagy could be one of the factors influencing resistance to therapy due to autophagic removal of damaged organelles and proteins formed under oxidative stress conditions. 46 As the cytoprotective role of autophagy could be a main obstacle in anticancer therapy, its inhibition should be a new strategy to explore. So far, different inhibitors of autophagy such as hydroxychloroquine, 3-methyladenine and bafilomycin A1 effectively sensitized cultured cancer cells to therapeutic agents. 47 It is noteworthy, that some autophagy inhibitors are tested in clinical trials. Currently, hydroxychloroquine in addition to the standard regimen is being explored in the treatment of cancer, including glioblastoma multiforme (http://clinicaltrials.gov/ct2/show/NCT00486603). 
MATERIALS AND METHODS
Reagents and antibodies
Cell culture and treatments
Rat C6 and human malignant LN18, LN229 and T98G glioma cells were purchased from American Type Culture Collection. Mouse pEGFP-N1 GL261 glioma cell line was a kind gift from Professor H Kettenmann, MDC, Berlin-Buch, Germany. Cells were cultured as described. 31, 43 Cell death was induced by 0.5 mg/ml adriamycin (Adr), 30 or 60 mM CsA or irradiation with UVC (100 J/m 2 , using a UVC-508 Ultraviolet Crosslinker) for indicated periods of time. In some experiments, 1 mg/ml cycloheximide (CHX) or 0.5 mg/ml actinomycin D (ActD) were added alone or 1 h before CsA. Rapamycin (Rap, 50 nM) or Earle's basal salt solution were used to activate autophagy. Bafilomycin A1 (BafA1, 10 nM) and 3-methyladenine (3MA, 2 mM) were used as inhibitors of autophagy. Thapsigargin (Tg, 1 mM) or tunicamycin (Tm, 10 mg/ml) inducers of ER stress. The eIF2a inhibitorsalubrinal (Sal, 50 mM), caspase inhibitor zVAD-FMK (20 mM or 40 mM) were added alone or simultaneously with CsA for 24 h.
Cell viability assayed by MTT metabolism or clonogenic survival assay
The cell viability was assayed by measuring the conversion of MTT to formazan as previously described. 39 For clonogenic assay, 48 h after transfection with siRNA targeting Atgs cells were seeded as a single cell suspension on 12-well plates (500 or 1000 cells per well), allowed to adhere for 18 h and treated with CsA (30 mM) for 5 h. Then the medium was replaced with drug-free medium, and cells were incubated for 10 days. Plates were stained with 0.1% crystal violet, and colonies were counted. Results were normalized to the colony-forming efficiency of the cells transfected with control siRNA.
Immunoblotting, immunofluorescence and immunohistochemistry
Western blot analysis was performed as previously described. 48 Cells grown on coverslips were fixed with 3% paraformaldehyde and postfixed with 100% methanol at À 20 1C. Primary antibodies anti-KDEL or anti-calreticulin were diluted in 1% bovine serum albumin containing 0.1% Triton X-100 and incubated with cells at 4 1C overnight. Antibodies were visualized with anti-rat or anti-mouse Alexa-555-conjugated secondary antibodies (Molecular Probes, Invitrogen, Paisley, UK). Cells were counterstained with 1 mg/ml DAPI.
Immunohistochemical staining was performed by incubating 20 mm sections with rabbit anti-LC3 antibody after blocking of endogenous peroxidase activity, epitope retrieval and blocking of nonspecific binding. After incubation with biotinylated secondary antibody and a peroxidaseconjugated extravidin, the peroxidase activity was developed in DABcontaining hydrogen peroxide. Sections were then counterstained with hematoxylin. DAB-stained tissues were visualized with a Leica DM4000B microscope and images were captured using Leica Application Suite version 2.8.1 (Wetzlar, Germany).
Electron Microscopy
The cells were fixed with 2% glutaraldehyde for 2 h, then postfixed in 1% osmium tetroxide for 1 h. Dehydration was done in increasing concentration of ethanol followed by propylene oxide. While incubated in 70% ethanol, the pellet was stained en bloc with 1% uranyl acetate. Finally the pellet was embedded in Epon resin. Ultrathin sections were poststained with uranyl acetate and Reynold's lead citrate routinely. Electron micrographs were taken with JEM 1400 transmission electron microscope at 80 kV (JEOL co., Tokyo, Japan, 2008).
Transfection, RNA interference with siRNA Transfections were performed using Lipofectamine 2000 reagent (Invitrogen). Cells were transfected with a plasmid coding for GFP-LC3 (kindly provided by Professor Aviva Tolkovsky, University of Cambridge, Cambridge, UK) and 24 h after transfection cells were treated with drugs for indicated period of time, then fixed with 3% paraformaldehyde and GFP-LC3 fluorescence was analyzed.
On-TARGET plus SMART pool siRNA human ULK1, ATG5 and ATG7 from Dharmacon (Thermo Scientific, Lafayette, CO, USA), FlexiTube siRNA human PERK and IRE1 from Qiagen (Hilden, Germany) were used. Glioma cells were cultured in 24-well or 12-well plates at a density of 5 Â 10 4 or 1 Â 10 5 cells per well, respectively and transfected with 30-60 nM siRNA. After 48 h, the cells were treated with CsA for the next 24 h, then harvested and analyzed for cell viability, western blot and caspase 3 activity. Gene knockdown efficacy was determined by western blots or RT-PCR.
Autophagy assay
To detect and quantify the AVOs in cells, the vital staining with acridine orange (1 mg/ml for 15 min) was performed. Red (4650 nm) fluorescence emission was measured with FACSCalibur using CellQuest software (BD Biosciences, Warsaw, Poland).
The pattern of GFP-LC3 in glioma cells transiently transfected with the fluorescent autophagy marker GFP-LC3 was then analyzed using fluorescence microscopy. A minimum of 100 cells per sample were counted at least in triplicates.
LC3 conversion assay. Lipidated LC3-II migrates more rapidly (B16 kDa) than LC3-I (B18 kDa) when proteins are separated by SDS-PAGE. Intensities of LC3-II band were quantified using NIH ImageJ software. The numbers below the blots represent average of duplicate or triplicate densitometric analysis of LC3-II normalized to the control.
Autophagic flux. To exclude that LC3-II increase is induced by inhibition of lysosomal degradation, treated cells were co-incubated with 10 nM bafilomycin A1 (BafA1) for the last 4 h.
Apoptosis assay
Levels of cleaved caspases 3, 7 and PARP were determined by western blotting. DNA fragmentation was detected by agarose electrophoresis of DNA and quantification of a sub-diploid population as previously described. 39 Caspase-3 activity was measured in cytosolic extracts using the colorimetric substrate Ac-DEVD-pNA as described. 
PCR analysis
Specific primers were used for XPB-1 forward 5 0 -CCTTGTAGTTGAGAAC CAGG-3 0 and reverse 5 0 -GGGGCTTGGTATATATGTGG-3 0 to generate 442 bp non-spliced and 416 bp spliced fragments. PCR reactions were resolved on a 2% agarose gel and PCR products were visualized with ethidium bromide staining or using Bioanalyzer (Agilent Technologies, Waldbronn, Germany).
Statistical analysis
Data were analyzed by Student's t-test or by Fisher post-hoc test (one-way analysis of variance) using Statistica (ver.8 StatSoft Inc., Tulsa, OK, USA) software and are presented as mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001 were considered statistically significant.
